Quantum Biopharma Ltd. Files July 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Jul 31, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Jul 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, company-update
TL;DR
Quantum Biopharma (fka FSD Pharma) filed its July 6-K, confirming its reporting status.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on July 31, 2025. The company, headquartered in Toronto, Canada, is reporting for the month of July 2025. Quantum Biopharma Ltd. is a pharmaceutical preparations company.
Why It Matters
This filing provides routine updates for Quantum Biopharma Ltd. as a foreign private issuer, informing investors about their ongoing reporting status with the SEC.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer
- FSD Pharma Inc. (company) — Former company name
- July 31, 2025 (date) — Filing date
- Toronto, Ontario, Canada (location) — Company headquarters
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of July 2025.
What was Quantum Biopharma Ltd.'s former name?
Quantum Biopharma Ltd.'s former name was FSD Pharma Inc., with a date of name change on March 27, 2019.
Where is Quantum Biopharma Ltd. located?
The company's principal executive office is located at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
Does Quantum Biopharma Ltd. file an annual report on Form 20-F or 40-F?
Quantum Biopharma Ltd. indicates it files or will file annual reports under cover of Form 20-F.
What is the Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd.?
The SIC code for Quantum Biopharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 31, 2025 regarding Quantum Biopharma Ltd. (QNTM).